T

Tongling Jieya Biologic Technology Co Ltd
SZSE:301108

Watchlist Manager
Tongling Jieya Biologic Technology Co Ltd
SZSE:301108
Watchlist
Price: 25.95 CNY -5.15% Market Closed
Market Cap: 2.1B CNY
Have any thoughts about
Tongling Jieya Biologic Technology Co Ltd?
Write Note

EV/EBIT
Enterprise Value to EBIT

16.6
Current
13.2
Median
12.9
Industry
Higher than median
Higher than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
16.6
=
Enterprise Value
1.1B CNY
/
EBIT
68m CNY
All Countries
Close

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
7
2-Years Forward
EV/EBIT
6
3-Years Forward
EV/EBIT
N/A

See Also

Discover More